Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -2.49 Million CAD | 78.28% |
| 2021 | -11.47 Million CAD | -162.14% |
| 2020 | -4.37 Million CAD | 1.81% |
| 2019 | -4.45 Million CAD | 43.99% |
| 2018 | -7.95 Million CAD | -416.05% |
| 2017 | -1.54 Million CAD | 31.75% |
| 2016 | -2.25 Million CAD | -461.03% |
| 2015 | -402.75 Thousand CAD | 80.01% |
| 2014 | -2.01 Million CAD | -308.28% |
| 2013 | -493.37 Thousand CAD | 73.94% |
| 2012 | -1.89 Million CAD | -8.84% |
| 2011 | -1.73 Million CAD | -2605.13% |
| 2010 | -64.29 Thousand CAD | 98.85% |
| 2009 | -5.61 Million CAD | 30.28% |
| 2008 | -8.05 Million CAD | -273.21% |
| 2007 | -2.15 Million CAD | -59.94% |
| 2006 | -1.34 Million CAD | 0.48% |
| 2005 | -1.35 Million CAD | -909.86% |
| 2004 | -134.23 Thousand CAD | 74.24% |
| 2003 | -521.05 Thousand CAD | -211.58% |
| 2002 | -167.23 Thousand CAD | -10.01% |
| 2001 | -152.01 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | 2.2 Million CAD | 352.16% |
| 2023 Q2 | -873.27 Thousand CAD | -5563.07% |
| 2023 Q1 | 15.98 Thousand CAD | 100.34% |
| 2022 Q1 | -1.32 Million CAD | 83.8% |
| 2022 FY | -2.49 Million CAD | 78.28% |
| 2022 Q4 | -4.66 Million CAD | -200.46% |
| 2022 Q3 | 4.64 Million CAD | 504.64% |
| 2022 Q2 | -1.14 Million CAD | 13.17% |
| 2021 Q2 | -2.31 Million CAD | -311.34% |
| 2021 Q1 | -562.26 Thousand CAD | 18.4% |
| 2021 FY | -11.47 Million CAD | -162.14% |
| 2021 Q4 | -8.16 Million CAD | -1777.59% |
| 2021 Q3 | -434.78 Thousand CAD | 81.2% |
| 2020 Q4 | -689.05 Thousand CAD | -18.23% |
| 2020 FY | -4.37 Million CAD | 1.81% |
| 2020 Q1 | -1.24 Million CAD | 5.8% |
| 2020 Q2 | -1.87 Million CAD | -50.63% |
| 2020 Q3 | -582.8 Thousand CAD | 68.84% |
| 2019 Q1 | -1.01 Million CAD | 54.37% |
| 2019 FY | -4.45 Million CAD | 43.99% |
| 2019 Q4 | -1.31 Million CAD | -9.7% |
| 2019 Q3 | -1.2 Million CAD | -29.75% |
| 2019 Q2 | -926.07 Thousand CAD | 8.45% |
| 2018 Q4 | -2.21 Million CAD | -26.57% |
| 2018 Q3 | -1.75 Million CAD | 35.59% |
| 2018 FY | -7.95 Million CAD | -416.05% |
| 2018 Q2 | -2.71 Million CAD | -114.04% |
| 2018 Q1 | -1.27 Million CAD | -239.89% |
| 2017 Q3 | -292.24 Thousand CAD | 23.4% |
| 2017 FY | -1.54 Million CAD | 31.75% |
| 2017 Q4 | -373.8 Thousand CAD | -27.91% |
| 2017 Q2 | -381.5 Thousand CAD | 21.91% |
| 2017 Q1 | -488.55 Thousand CAD | 24.69% |
| 2016 Q1 | -121.88 Thousand CAD | -6.95% |
| 2016 FY | -2.25 Million CAD | -461.03% |
| 2016 Q4 | -648.69 Thousand CAD | -0.83% |
| 2016 Q3 | -643.37 Thousand CAD | 30.08% |
| 2016 Q2 | -920.11 Thousand CAD | -654.91% |
| 2015 Q2 | -100.73 Thousand CAD | 4.89% |
| 2015 Q4 | -113.96 Thousand CAD | -38.72% |
| 2015 Q3 | -82.15 Thousand CAD | 18.44% |
| 2015 FY | -402.75 Thousand CAD | 80.01% |
| 2015 Q1 | -105.91 Thousand CAD | 92.53% |
| 2014 Q1 | -90.47 Thousand CAD | -39.4% |
| 2014 FY | -2.01 Million CAD | -308.28% |
| 2014 Q2 | -98.97 Thousand CAD | -9.39% |
| 2014 Q4 | -1.41 Million CAD | -248.64% |
| 2014 Q3 | -406.76 Thousand CAD | -311.0% |
| 2013 Q1 | -136.26 Thousand CAD | 90.56% |
| 2013 FY | -493.37 Thousand CAD | 73.94% |
| 2013 Q4 | -64.9 Thousand CAD | 60.74% |
| 2013 Q3 | -165.31 Thousand CAD | -30.28% |
| 2013 Q2 | -126.89 Thousand CAD | 6.88% |
| 2012 Q4 | -1.44 Million CAD | -710.25% |
| 2012 Q3 | -178.2 Thousand CAD | 2.67% |
| 2012 FY | -1.89 Million CAD | -8.84% |
| 2012 Q2 | -183.1 Thousand CAD | -108.82% |
| 2012 Q1 | -87.68 Thousand CAD | 37.45% |
| 2011 Q3 | -1.69 Million CAD | -128.21% |
| 2011 FY | -1.73 Million CAD | -2605.13% |
| 2011 Q4 | -140.18 Thousand CAD | 91.75% |
| 2011 Q1 | 845.2 Thousand CAD | 106.15% |
| 2011 Q2 | -744.7 Thousand CAD | -188.11% |
| 2010 Q2 | 463.61 Thousand CAD | 210.66% |
| 2010 Q3 | -518.96 Thousand CAD | -211.94% |
| 2010 Q4 | 410 Thousand CAD | 179.0% |
| 2010 Q1 | -418.95 Thousand CAD | 91.83% |
| 2010 FY | -64.29 Thousand CAD | 98.85% |
| 2009 FY | -5.61 Million CAD | 30.28% |
| 2009 Q4 | -5.12 Million CAD | -2168.87% |
| 2009 Q3 | 247.93 Thousand CAD | 322.07% |
| 2009 Q1 | -621.04 Thousand CAD | 83.23% |
| 2009 Q2 | -111.64 Thousand CAD | 82.02% |
| 2008 Q2 | -1.16 Million CAD | -225.24% |
| 2008 FY | -8.05 Million CAD | -273.21% |
| 2008 Q4 | -3.7 Million CAD | -31.04% |
| 2008 Q3 | -2.82 Million CAD | -142.39% |
| 2008 Q1 | -358.41 Thousand CAD | -425.67% |
| 2007 FY | -2.15 Million CAD | -59.94% |
| 2007 Q1 | -258.26 Thousand CAD | -11.21% |
| 2007 Q3 | -212.04 Thousand CAD | 86.9% |
| 2007 Q4 | -68.18 Thousand CAD | 67.85% |
| 2007 Q2 | -1.61 Million CAD | -526.9% |
| 2006 Q1 | -132.96 Thousand CAD | 70.53% |
| 2006 Q2 | -339.24 Thousand CAD | -155.13% |
| 2006 Q3 | -644.56 Thousand CAD | -90.0% |
| 2006 Q4 | -232.22 Thousand CAD | 63.97% |
| 2006 FY | -1.34 Million CAD | 0.48% |
| 2005 Q3 | -423.95 Thousand CAD | -401.32% |
| 2005 Q4 | -451.15 Thousand CAD | -6.42% |
| 2005 Q2 | -84.56 Thousand CAD | 78.64% |
| 2005 Q1 | -395.89 Thousand CAD | -993.84% |
| 2005 FY | -1.35 Million CAD | -909.86% |
| 2004 Q4 | -36.19 Thousand CAD | 8.1% |
| 2004 Q1 | -25.99 Thousand CAD | 93.73% |
| 2004 Q3 | -39.38 Thousand CAD | -20.6% |
| 2004 Q2 | -32.65 Thousand CAD | -25.62% |
| 2004 FY | -134.23 Thousand CAD | 74.24% |
| 2003 Q1 | -32.31 Thousand CAD | 20.63% |
| 2003 FY | -521.05 Thousand CAD | -211.58% |
| 2003 Q2 | -35.45 Thousand CAD | -9.73% |
| 2003 Q4 | -414.38 Thousand CAD | -959.84% |
| 2003 Q3 | -39.09 Thousand CAD | -10.28% |
| 2002 Q3 | -40.12 Thousand CAD | 12.63% |
| 2002 Q4 | -40.7 Thousand CAD | -1.46% |
| 2002 FY | -167.23 Thousand CAD | -10.01% |
| 2002 Q1 | -40.14 Thousand CAD | 0.0% |
| 2002 Q2 | -45.92 Thousand CAD | -14.41% |
| 2001 FY | -152.01 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.16 Million USD | 93.637% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -113.923% |
| Össur hf. | 58.38 Million USD | 104.268% |
| QHSLab, Inc. | -468.36 Thousand USD | -432.111% |
| Wellstar International, Inc. | -3.1 Million USD | 19.825% |
| Össur hf. | 58.38 Million USD | 104.268% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -125.26 Thousand USD | -1889.611% |
| Aurora Spine Corporation | -1.68 Million USD | -48.296% |
| BrainsWay Ltd. | -4.19 Million USD | 40.619% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -244.793% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -310.563% |
| Vivos Inc. | -2.89 Million USD | 13.906% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -1040.75% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -40.182% |
| Zecotek Photonics Inc. | -3.51 Million USD | 29.178% |
| Avitar, Inc. | -2.25 Million USD | -10.293% |
| Nanomix Corporation | -12.33 Million USD | 79.792% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 205.961% |
| Theraclion SA | -3.67 Million USD | 32.185% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.63 Million USD | -52.084% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 5.643% |
| Lombard Medical, Inc. | -31.03 Million USD | 91.97% |
| ALR Technologies Inc. | -11.89 Million USD | 79.051% |
| Stratec SE | 14.42 Million USD | 117.276% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -3476.082% |
| Heart Tronics, Inc. | -13.32 Million USD | 81.3% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.478% |
| VMS Rehab Systems, Inc. | 46.44 USD | 5366609.475% |
| NewCardio, Inc. | -11.49 Million USD | 78.322% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 28.57% |
| Ingen Technologies, Inc. | -5.06 Million USD | 50.761% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -175.148% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -496.175% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -230.979% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 90.343% |
| IR-Med Inc. | -4.9 Million USD | 49.232% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 82.244% |
| Polarean Imaging plc | -11.88 Million USD | 79.03% |
| United American Healthcare Corporation | 723 Thousand USD | 444.704% |
| ECGI Holdings, Inc. | -3.61 Million USD | 30.981% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -1885.411% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -278.741% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -247.66% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 731.194% |
| Urologix, Inc. | -7.6 Million USD | 67.242% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -47.137% |
| Nexeon MedSystems Inc. | -2.17 Million USD | -14.445% |
| SS Innovations International, Inc. | -20.94 Million USD | 88.099% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -209.583% |
| Smith & Nephew plc | 263 Million USD | 100.948% |
| NIOX Group Plc | 13.64 Million USD | 118.271% |
| Fuse Medical, Inc. | 1.45 Million USD | 270.703% |
| Broncus Holding Corporation | -28.09 Million USD | 91.128% |
| Brain Scientific Inc. | -12.34 Million USD | 79.81% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 91.498% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -1455.219% |